Nicord Single Unit Expanded Umbilical Cord Blood Transplantation (UCBT): Final Results of a Multicenter Phase I/II Trial

被引：0

作者：

Horwitz, Mitchell E. ^{[1
]}

Cilloni, Daniela ^{[2
]}

Valcarcel, David ^{[3
]}

Frassoni, Francesco ^{[4
]}

Boelens, Jaap-Jan ^{[5
]}

Jagasia, Madan ^{[6
]}

Wagner, John E. ^{[7
]}

Kuball, Jurgen ^{[8
]}

Koh, Liang Piu ^{[9
]}

Majhail, Navneet S. ^{[10
]}

Stiff, Patrick J. ^{[11
]}

Hanna, Rabi ^{[12
]}

Maziarz, Richard T. ^{[13
]}

Hwang, William Ying Khee ^{[14
]}

Montesinos, Pau ^{[15
]}

Kurtzberg, Joanne ^{[16
]}

Sanz, Guillermo ^{[17
]}

机构：

[1] Duke Univ, Med Ctr, Dept Med, Adult Stem Cell Transplant Program,Div Cellular T, Durham, NC 27710 USA

[2] Univ Turin, Turin, Italy

[3] Carlson Wagonlit Espana, Madrid, Spain

[4] San Martino Hosp, Dept Hematol 2, Genoa, Italy

[5] Univ Med Ctr Utrecht, Pediat Blood & Marrow Transplantat Program, Utrecht, Netherlands

[6] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[7] Univ Minnesota, Dept Pediat, Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

[8] Univ Med Ctr Utrecht, Blood & Marrow Transplantat Program, Utrecht, Netherlands

[9] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore

[10] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Blood & Marrow Transplantat, Cleveland, OH 44106 USA

[11] Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA

[12] Cleveland Clin, Dept Pediat Hematol & Oncol, Pediat Blood & Marrow Transplantat, Cleveland, OH 44106 USA

[13] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[14] Singapore Gen Hosp, Dept Hematol, Singapore, Singapore

[15] Hosp Univ La Fe, Valencia, Spain

[16] Duke Univ, Med Ctr, Durham, NC USA

[17] Hosp Univ & Politecn La Fe, Serv Hematol, Valencia, Spain

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期

关键词：

D O I：

10.1016/j.bbmt.2017.12.628

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S57 / S57

页数：1

共 50 条

[21] Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study
Frangoul, H.
Wang, L.
Harrell, F. E., Jr.
Manes, B.
Calder, C.
Domm, J.
BONE MARROW TRANSPLANTATION, 2010, 45 (02) : 283 - 288
[22] Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System
Jaroscak, J
Goltry, K
Smith, A
Waters-Pick, B
Martin, PL
Driscoll, TA
Howrey, R
Chao, N
Douville, J
Burhop, S
Fu, PF
Kurtzberg, J
BLOOD, 2003, 101 (12) : 5061 - 5067
[23] Umbilical cord blood transplantation (UCBT) at the University of Minnesota: Impact of double unit and fludarabine on engraftment after myeloablative conditioning.
Brunstein, Claudio G.
Defor, Todd
Wagner, John E.
BLOOD, 2006, 108 (11) : 888A - 888A
[24] Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial
Abraham, Allistair
Cluster, Andrew
Jacobsohn, David
Delgado, David
Hulbert, Monica L.
Kukadiya, Divyesh
Murray, Lisa
Shenoy, Shalini
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1587 - 1592
[25] Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Kurtzberg, Joanne
Carter, Shelly L.
Mendizabal, Adam
Wall, Donna A.
Schultz, Kirk R.
Kernan, Nancy A.
Eapen, Mary
Wagner, John E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S121 - S121
[26] NiCORD® EXPANDED HEMATOPOIETIC PROGENITOR CELLS (HPC) ARE CAPABLE OF PROLONGED MYELOID AND LYMPHOID ENGRAFTMENT FOLLOWING MYELOABLATIVE DUAL UMBILICAL CORD BLOOD (UCB) TRANSPLANTATION
Horwitz, M.
Chao, N.
Rizzieri, D.
Long, G.
Sullivan, K.
Gasparetto, C.
Chute, J.
Morris, A.
McDonald, C.
Snyder, D.
Galamidi, E.
Srur-Kidron, O.
Shoham, H.
Landau, E.
Friend, E.
Kurtzberg, J.
Peled, T.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S326 - S326
[27] StemEx®(Copper Chelation Based) Ex Vivo Expanded Umbilical Cord Blood Stem Cell Transplantation (UCBT) Accelerates Engraftment and Improves 100 Day Survival In Myeloablated Patients Compared To a Registry Cohort Undergoing Double Unit UCBT: Results Of a Multicenter Study Of 101 Patients With Hematologic Malignancies
Stiff, Patrick J.
Montesinos, Pau
Peled, Tony
Landau, Efrat
Rosenheimer, Noga
Mandel, Julie
Hasson, Nira
Olesinski, Esti
Glukhman, Ela
Snyder, David A.
Galamidi, Einat
Kidron, Orna Srur
Bracha, Dalia
Harati, Dorit
Ben-Abu, Keren
Freind, Etty
Freedman, Laurence
Cohen, Yael C.
Olmer, Liraz
Barishev, Raya
Rocha, Vanderson
Horowitz, Mary M.
Eapen, Mary
Nagler, Arnon
Sanz, Guillermo
BLOOD, 2013, 122 (21)
[28] Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial
M L MacMillan
B R Blazar
T E DeFor
J E Wagner
Bone Marrow Transplantation, 2009, 43 : 447 - 454
[29] Long-term outcome and prognostic factors after single-unit umbilical cord-blood transplantation (UCBT) for adults with hematologic malignancies.
Sanz, Guillermo
Cantero, Susana
Larrea, Luis
Planelles, Dolores
Lorenzo, Ignacio
Bandloch, Barbara
Banlloch, Luis
Senent, Leonor
Montesinos, Pau
Cervera, Jose
Jimenez, Carmen
Martin, Guillermo
Martinez, Jesus
Jarque, Isidro
De la Rubia, Javier
Sanz, Miguel A.
BLOOD, 2006, 108 (11) : 892A - 893A
[30] RISK FACTORS ASSOCIATED WITH GRAFT FAILURE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION (UCBT): A SINGLE CENTER ANALYSIS IN 539 PATIENTS
Doshi, K.
Brunstein, C. G.
Cao, Q.
Wagner, J. E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 5 - 6

← 1 2 3 4 5 →